The Optibrium team works at the forefront of decision-analysis and predictive modelling research, developing innovative products that enhance the efficiency and productivity of drug discovery.
StarDrop™ is a complete package of fully integrated, elegant software for small molecule design, optimisation and data analysis.
Keep up to date
News & Events
Optibrium receives further investment from Kester Capital Second round of funding from existing investors will further drive company expansion and commercial growth of its AI-enabled drug discovery technology. CAMBRIDGE, UK, 21 June 2022 – Optibrium™, a developer ... Read More
Optimising Operations & Processes in Biotech Labs Recent developments in computational tools and how these can solve operational challenges in biotech labs. Interview published by Lab Manager: – Biotechnology labs face many challenges, such as operations and ... Read More
Optibrium expands UK head office with new facilities on Cambridge Innovation Park Investment in new headquarters forms part of ongoing company growth plans. The new facility supports the continued success of Optibrium's drug discovery technologies and accommodates Read More
Our latest news
The investment will be used to further develop and commercialise Optibrium’s computer-aided drug discovery technologies, with future appointments to the senior leadership team and continued expansion across Europe and the United States.
Founded in 2009, Optibrium continues to develop new products and research novel technologies to improve the efficiency and productivity of drug discovery. Optibrium works closely with its broad range of customers and collaborators that include leading global pharma, agrochemical and flavouring companies, biotechs and academic groups.
Got an Enquiry?
Get In Touch
To trial any of our products or to find out more about Optibrium, please complete the contact form and add details of your particular interest. Further information on our office locations and details can be found on our Contact page.